REGENERON PHARMACEUTICALS, INC. Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for November 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 19.69 | 3,000 | 59,070 | 7,000 | |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 500 | 290,000 | 4,500 | 5 K to 4.5 K (-10.00 %) |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 3,000 | 1,740,000 | 112,772 | 115.8 K to 112.8 K (-2.59 %) |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 19.69 | 3,000 | 59,070 | 115,772 | 112.8 K to 115.8 K (+2.66 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 455 | 0 | 153,935 | 154.4 K to 153.9 K (-0.29 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 1,731 | 0 | 332,880 | 334.6 K to 332.9 K (-0.52 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 586.73 | 3,474 | 2,038,300 | 334,611 | 338.1 K to 334.6 K (-1.03 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 587.58 | 3,539 | 2,079,446 | 338,085 | 341.6 K to 338.1 K (-1.04 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 588.40 | 10,227 | 6,017,567 | 341,624 | 351.9 K to 341.6 K (-2.91 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,486 | 168,036 | 42,195 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,700 | 174,591 | 47,681 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 557.14 | 1,223 | 681,382 | 0 | 1.2 K to 0 (-100.00 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 556.00 | 1,000 | 556,000 | 1,223 | 2.2 K to 1.2 K (-44.98 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 554.39 | 2,000 | 1,108,780 | 2,223 | 4.2 K to 2.2 K (-47.36 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 552.50 | 50 | 27,625 | 4,223 | 4.3 K to 4.2 K (-1.17 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 551.45 | 850 | 468,733 | 4,273 | 5.1 K to 4.3 K (-16.59 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,674 | 1,496,076 | 5,123 | 7.8 K to 5.1 K (-34.30 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 300 | 167,847 | 7,797 | 8.1 K to 7.8 K (-3.71 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,486 | 168,036 | 8,097 | 2.6 K to 8.1 K (+210.11 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,778 | 1,554,263 | 2,611 | 5.4 K to 2.6 K (-51.55 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 311 | 174,001 | 5,389 | 5.7 K to 5.4 K (-5.46 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,700 | 174,591 | 5,700 | 0 to 5.7 K |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 75,000 | 2,297,250 | 46,736 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 25,000 | 531,250 | 20,295 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.41 | 900 | 507,069 | 22,029 | 22.9 K to 22 K (-3.93 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.31 | 5,607 | 3,152,872 | 22,929 | 28.5 K to 22.9 K (-19.65 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 561.36 | 500 | 280,680 | 28,536 | 29 K to 28.5 K (-1.72 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 560.31 | 3,900 | 2,185,209 | 29,036 | 32.9 K to 29 K (-11.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 559.26 | 1,500 | 838,890 | 32,936 | 34.4 K to 32.9 K (-4.36 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 558.37 | 9,694 | 5,412,839 | 34,436 | 44.1 K to 34.4 K (-21.97 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 564.19 | 2,100 | 1,184,799 | 44,130 | 46.2 K to 44.1 K (-4.54 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.43 | 8,345 | 4,701,823 | 46,230 | 54.6 K to 46.2 K (-15.29 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.37 | 9,555 | 5,373,445 | 54,575 | 64.1 K to 54.6 K (-14.90 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 13,312 | 7,556,291 | 64,130 | 77.4 K to 64.1 K (-17.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 935 | 530,734 | 77,442 | 78.4 K to 77.4 K (-1.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 25,000 | 531,250 | 78,377 | 53.4 K to 78.4 K (+46.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 39,605 | 22,480,986 | 53,377 | 93 K to 53.4 K (-42.59 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 4,047 | 2,297,199 | 92,982 | 97 K to 93 K (-4.17 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 75,000 | 2,297,250 | 97,029 | 22 K to 97 K (+340.46 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,000 | 0 | 16,405 | 17.4 K to 16.4 K (-5.75 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 414 | 0 | 154,390 | 154.8 K to 154.4 K (-0.27 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 462 | 0 | 154,804 | 155.3 K to 154.8 K (-0.30 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 511 | 0 | 155,266 | 155.8 K to 155.3 K (-0.33 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 580.23 | 3,985 | 2,312,217 | 351,851 | 355.8 K to 351.9 K (-1.12 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 580.18 | 13,257 | 7,691,446 | 355,836 | 369.1 K to 355.8 K (-3.59 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 11.64 | 182,818 | 2,128,002 | 0 | |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 580.29 | 400 | 232,116 | 543,348 | 543.7 K to 543.3 K (-0.07 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 579.53 | 1,500 | 869,295 | 543,748 | 545.2 K to 543.7 K (-0.28 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 578.73 | 268 | 155,100 | 545,248 | 545.5 K to 545.2 K (-0.05 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 577.58 | 1,996 | 1,152,850 | 545,516 | 547.5 K to 545.5 K (-0.36 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 576.48 | 865 | 498,655 | 547,512 | 548.4 K to 547.5 K (-0.16 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 575.64 | 2,441 | 1,405,137 | 548,377 | 550.8 K to 548.4 K (-0.44 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 574.55 | 2,693 | 1,547,263 | 550,818 | 553.5 K to 550.8 K (-0.49 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 573.47 | 2,629 | 1,507,653 | 553,511 | 556.1 K to 553.5 K (-0.47 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 572.43 | 5,723 | 3,276,017 | 556,140 | 561.9 K to 556.1 K (-1.02 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 571.41 | 7,800 | 4,456,998 | 561,863 | 569.7 K to 561.9 K (-1.37 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 570.67 | 6,330 | 3,612,341 | 569,663 | 576 K to 569.7 K (-1.10 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 569.47 | 2,223 | 1,265,932 | 575,993 | 578.2 K to 576 K (-0.38 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 568.49 | 1,600 | 909,584 | 578,216 | 579.8 K to 578.2 K (-0.28 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 567.61 | 1,350 | 766,274 | 579,816 | 581.2 K to 579.8 K (-0.23 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 566.66 | 1,700 | 963,322 | 581,166 | 582.9 K to 581.2 K (-0.29 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 565.89 | 1,000 | 565,890 | 582,866 | 583.9 K to 582.9 K (-0.17 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 564.57 | 1,000 | 564,570 | 583,866 | 584.9 K to 583.9 K (-0.17 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 563.76 | 530 | 298,793 | 584,866 | 585.4 K to 584.9 K (-0.09 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 562.36 | 100 | 56,236 | 585,396 | 585.5 K to 585.4 K (-0.02 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 561.75 | 1,200 | 674,100 | 585,496 | 586.7 K to 585.5 K (-0.20 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 559.08 | 92,316 | 51,612,029 | 586,696 | 679 K to 586.7 K (-13.60 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 559.08 | 3,806 | 2,127,858 | 679,012 | 682.8 K to 679 K (-0.56 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 11.64 | 182,818 | 2,128,002 | 682,818 | 500 K to 682.8 K (+36.56 %) |